160 related articles for article (PubMed ID: 25412507)
1. Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesis.
Hooper CM; Hawes SM; Kees UR; Gottardo NG; Dallas PB
PLoS One; 2014; 9(11):e112909. PubMed ID: 25412507
[TBL] [Abstract][Full Text] [Related]
2. Single-cell spatial transcriptomic analysis reveals common and divergent features of developing postnatal granule cerebellar cells and medulloblastoma.
Luo W; Lin GN; Song W; Zhang Y; Lai H; Zhang M; Miao J; Cheng X; Wang Y; Li W; Wei W; Gao WQ; Yang R; Wang J
BMC Biol; 2021 Jul; 19(1):135. PubMed ID: 34210306
[TBL] [Abstract][Full Text] [Related]
3. ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.
Lang PY; Nanjangud GJ; Sokolsky-Papkov M; Shaw C; Hwang D; Parker JS; Kabanov AV; Gershon TR
Development; 2016 Nov; 143(21):4038-4052. PubMed ID: 27803059
[TBL] [Abstract][Full Text] [Related]
4. Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development.
Williamson D; Schwalbe EC; Bailey S; Clifford SC
Neuropathol Appl Neurobiol; 2023 Jun; 49(3):e12903. PubMed ID: 37021628
[TBL] [Abstract][Full Text] [Related]
5. Childhood cerebellar tumours mirror conserved fetal transcriptional programs.
Vladoiu MC; El-Hamamy I; Donovan LK; Farooq H; Holgado BL; Sundaravadanam Y; Ramaswamy V; Hendrikse LD; Kumar S; Mack SC; Lee JJY; Fong V; Juraschka K; Przelicki D; Michealraj A; Skowron P; Luu B; Suzuki H; Morrissy AS; Cavalli FMG; Garzia L; Daniels C; Wu X; Qazi MA; Singh SK; Chan JA; Marra MA; Malkin D; Dirks P; Heisler L; Pugh T; Ng K; Notta F; Thompson EM; Kleinman CL; Joyner AL; Jabado N; Stein L; Taylor MD
Nature; 2019 Aug; 572(7767):67-73. PubMed ID: 31043743
[TBL] [Abstract][Full Text] [Related]
6. Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.
Luo Z; Xia M; Shi W; Zhao C; Wang J; Xin D; Dong X; Xiong Y; Zhang F; Berry K; Ogurek S; Liu X; Rao R; Xing R; Wu LMN; Cui S; Xu L; Lin Y; Ma W; Tian S; Xie Q; Zhang L; Xin M; Wang X; Yue F; Zheng H; Liu Y; Stevenson CB; de Blank P; Perentesis JP; Gilbertson RJ; Li H; Ma J; Zhou W; Taylor MD; Lu QR
Nature; 2022 Dec; 612(7941):787-794. PubMed ID: 36450980
[TBL] [Abstract][Full Text] [Related]
7. Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile.
Malawsky DS; Weir SJ; Ocasio JK; Babcock B; Dismuke T; Cleveland AH; Donson AM; Vibhakar R; Wilhelmsen K; Gershon TR
Commun Biol; 2021 May; 4(1):616. PubMed ID: 34021242
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a metabolism-related gene signature for predicting the prognosis of paediatric medulloblastoma.
Su J; Xie Q; Xie L
Sci Rep; 2024 Mar; 14(1):7540. PubMed ID: 38553479
[TBL] [Abstract][Full Text] [Related]
9. Unified rhombic lip origins of group 3 and group 4 medulloblastoma.
Smith KS; Bihannic L; Gudenas BL; Haldipur P; Tao R; Gao Q; Li Y; Aldinger KA; Iskusnykh IY; Chizhikov VV; Scoggins M; Zhang S; Edwards A; Deng M; Glass IA; Overman LM; Millman J; Sjoboen AH; Hadley J; Golser J; Mankad K; Sheppard H; Onar-Thomas A; Gajjar A; Robinson GW; Hovestadt V; Orr BA; Patay Z; Millen KJ; Northcott PA
Nature; 2022 Sep; 609(7929):1012-1020. PubMed ID: 36131015
[TBL] [Abstract][Full Text] [Related]
10. The pivotal role of irradiation-induced apoptosis in the pathogenesis and therapy of medulloblastoma.
Richard SA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2048. PubMed ID: 38599791
[TBL] [Abstract][Full Text] [Related]
11. Unusual pattern of metastatic disease in a patient in their early childhood with group 4 medulloblastoma.
Ho C; Malicki D; Levy M; Crawford JR
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37142287
[No Abstract] [Full Text] [Related]
12. Three down and one to go: modeling medulloblastoma subgroups.
Eberhart CG
Cancer Cell; 2012 Feb; 21(2):137-8. PubMed ID: 22340583
[TBL] [Abstract][Full Text] [Related]
13. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.
Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW
Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003
[TBL] [Abstract][Full Text] [Related]
14. SnapShot: Medulloblastoma.
Rusert JM; Wu X; Eberhart CG; Taylor MD; Wechsler-Reya RJ
Cancer Cell; 2014 Dec; 26(6):940-940.e1. PubMed ID: 25490452
[TBL] [Abstract][Full Text] [Related]
15. Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Hill RM; Kuijper S; Lindsey JC; Petrie K; Schwalbe EC; Barker K; Boult JK; Williamson D; Ahmad Z; Hallsworth A; Ryan SL; Poon E; Robinson SP; Ruddle R; Raynaud FI; Howell L; Kwok C; Joshi A; Nicholson SL; Crosier S; Ellison DW; Wharton SB; Robson K; Michalski A; Hargrave D; Jacques TS; Pizer B; Bailey S; Swartling FJ; Weiss WA; Chesler L; Clifford SC
Cancer Cell; 2015 Jan; 27(1):72-84. PubMed ID: 25533335
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma subgroups remain stable across primary and metastatic compartments.
Wang X; Dubuc AM; Ramaswamy V; Mack S; Gendoo DM; Remke M; Wu X; Garzia L; Luu B; Cavalli F; Peacock J; López B; Skowron P; Zagzag D; Lyden D; Hoffman C; Cho YJ; Eberhart C; MacDonald T; Li XN; Van Meter T; Northcott PA; Haibe-Kains B; Hawkins C; Rutka JT; Bouffet E; Pfister SM; Korshunov A; Taylor MD
Acta Neuropathol; 2015 Mar; 129(3):449-57. PubMed ID: 25689980
[TBL] [Abstract][Full Text] [Related]
17. Deregulated proliferation and differentiation in brain tumors.
Swartling FJ; Čančer M; Frantz A; Weishaupt H; Persson AI
Cell Tissue Res; 2015 Jan; 359(1):225-54. PubMed ID: 25416506
[TBL] [Abstract][Full Text] [Related]
18. Embryonal brain tumors.
McGovern SL; Grosshans D; Mahajan A
Cancer J; 2014; 20(6):397-402. PubMed ID: 25415685
[TBL] [Abstract][Full Text] [Related]
19. Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.
Ecker J; Oehme I; Mazitschek R; Korshunov A; Kool M; Hielscher T; Kiss J; Selt F; Konrad C; Lodrini M; Deubzer HE; von Deimling A; Kulozik AE; Pfister SM; Witt O; Milde T
Acta Neuropathol Commun; 2015 Apr; 3():22. PubMed ID: 25853389
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of human Sonic Hedgehog (SHH) medulloblastoma stem-like cells.
Ronci M; Catanzaro G; Pieroni L; Po A; Besharat ZM; Greco V; Levi Mortera S; Screpanti I; Ferretti E; Urbani A
Mol Biosyst; 2015 Jun; 11(6):1603-11. PubMed ID: 25756958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
